Advertisement
Research Article| Volume 310, ISSUE 1-2, P86-89, November 15, 2011

Download started.

Ok

Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)

Published:September 01, 2011DOI:https://doi.org/10.1016/j.jns.2011.07.047
Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)
Previous ArticleClinical approach to nonmotor sensory fluctuations in Parkinson's disease
Next ArticleDopamine-depletion and increased α-synuclein load induce degeneration of cortical cholinergic fibers in mice

      Abstract

      Introduction

      In 2004 we described the mutation E46K of the α-Synuclein (SNCA). These patients show Parkinson's disease with early cognitive impairment, sleep disorders and autonomic dysfunction.

      Objective

      The main objective is to identify early neuropsychological impairments in patients with the E46K mutation.

      Methods

      This is a longitudinal neuropsychological study of 4 of the 5 surviving patients with E46K mutation by semi-structured interviews and the following scales: Mattis Dementia Rating Scale (MDRS), semantic and phonemic verbal fluency tests (VFT), Benton Visual Retention Test (BVRT), Stroop Test (STROOP), Clock drawing test (CLOCK), WAIS III Letter and Number sequencing (WAIS III LN), Rey Auditory Verbal Learning Test (RAVLT) and Benton Judgement of Line Orientation Test (BJLOT). Motor status was assessed by UPDRS III.

      Results

      Motor status: Patients 1, 2 and 3 present mild to moderate Parkinson disease of 7, 8 and 3 years of evolution respectively, patient 4 is asymptomatic.
      Cognitive status: Patient 2 and 3 both refer cognitive decline while patient 1 presents no cognitive complaints, however they all show a progressive cognitive decline across various tasks. Tests of frontal function showed the first alterations in all patients but fluctuate. The first cognitive complaints coincide with deterioration of tasks of posterior cortical basis. Patient 4 presents a normal performance on all tests. Patient 1, 2 and 3 have all presented visual hallucinations.

      Conclusions

      A fluctuating frontal impairment is observed at early stages. Prominent visuospatial alterations and visual hallucinations suggest that posterior cortical dysfunction might be a distinct early feature of the cognitive impairment observed in patients with this mutation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Zarranz J.J.
        • Alegre J.
        • Gomez-Esteban J.C.
        • Lezcano E.
        • Ros R.
        • Ampuero I.
        • et al.
        The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
        Ann Neurol. 2004 Feb; 55: 164-173
        View in Article
        • Aarsland D.
        • Zaccai J.
        • Brayne C.
        A systematic review of prevalence studies of dementia in Parkinson's disease.
        Mov Disord. 2005 Oct; 20: 1255-1263
        View in Article
        • Hughes A.J.
        • Daniel S.E.
        • Kilford L.
        • Lees A.J.
        Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
        J Neurol Neurosurg Psychiatry. 1992 Mar; 55: 181-184
        View in Article
        • Tijero B.
        • Gomez-Esteban J.C.
        • Llorens V.
        • Lezcano E.
        • Gonzalez-Fernandez M.C.
        • de Pancorbo M.M.
        • et al.
        Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).
        Clin Auton Res. 2010 Aug; 20: 267-269
        View in Article
        • Williams-Gray C.H.
        • Foltynie T.
        • Brayne C.E.
        • Robbins T.W.
        • Barker R.A.
        Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.
        Brain. 2007 Jul; 130: 1787-1798
        View in Article
        • Williams-Gray C.H.
        • Evans J.R.
        • Goris A.
        • Foltynie T.
        • Ban M.
        • Robbins T.W.
        • et al.
        The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.
        Brain. 2009 Nov; 132: 2958-2969
        View in Article
        • Lee J.E.
        • Park H.J.
        • Song S.K.
        • Sohn Y.H.
        • Lee J.D.
        • Lee P.H.
        Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.
        Neurology. 2010 Nov 30; 75: 2009-2016
        View in Article
        • Uc E.Y.
        • McDermott M.P.
        • Marder K.S.
        • Anderson S.W.
        • Litvan I.
        • Como P.G.
        • et al.
        Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.
        Neurology. 2009 Nov 3; 73: 1469-1477
        View in Article
        • Hobson P.
        • Meara J.
        Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.
        Mov Disord. 2004 Sep; 19: 1043-1049
        View in Article
        • Dujardin K.
        • Defebvre L.
        • Grunberg C.
        • Becquet E.
        • Destee A.
        Memory and executive function in sporadic and familial Parkinson's disease.
        Brain. 2001 Feb; 124: 389-398
        View in Article
        • Inzelberg R.
        • Schecthman E.
        • Paleacu D.
        • Zach L.
        • Bonwitt R.
        • Carasso R.L.
        • et al.
        Onset and progression of disease in familial and sporadic Parkinson's disease.
        Am J Med Genet A. 2004 Jan 30; 124: 255-258
        View in Article
        • Inzelberg R.
        • Polyniki A.
        Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia?.
        J Neurol Sci. 2010 Feb 15; 289: 23-26
        View in Article
        • Caccappolo E.
        • Alcalay R.N.
        • Mejia-Santana H.
        • Tang M.X.
        • Rakitin B.
        • Rosado L.
        • et al.
        Neuropsychological Profile of Parkin Mutation Carriers With and Without Parkinson Disease: The CORE-PD Study.
        J Int Neuropsychol Soc. 2011 Nov; 24: 1-10
        View in Article

      Article info

      Publication history

      Published online: September 01, 2011
      Accepted: July 26, 2011
      Received in revised form: June 29, 2011
      Received: March 14, 2011

      Identification

      DOI: https://doi.org/10.1016/j.jns.2011.07.047

      Copyright

      © 2011 Elsevier B.V. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX